FY 2008 Appropriations for R&D and Public Health Programs (in millions)

Size: px
Start display at page:

Download "FY 2008 Appropriations for R&D and Public Health Programs (in millions)"

Transcription

1 FY 2008 Appropriations for R&D and Public Health Programs (in millions) AGENCY PROGRAM FY 2008 Appropriations Status: FY 2008 : Agency s: 10/26/07 PB % PB % PB National Institutes of Health* $28,899 $28, % $29, % ** 3.6% $29, %** 4.5% NCI $4,798 $4, % $4, % 1.8% $4, % 2.7% NHLBI $2,923 $2, % $2, % 1.4% $2, % 2.3% NIDCR $390 $ % $ % 1.5% $ % 2.3% NIDDK $1,706 $1, % $1, % 1.4% $1, % 2.3% NINDS $1,536 $1, % $1, % 1.4% $1, % 2.3% NIAID ** $4,368 $4, % $4, % 0.9% $4, % 1.7% NIGMS $1,936 $1, % $1, % 1.3% $1, % 2.0% NICHD $1,255 $1, % $1, % 0.7% $1, % 1.3% NEI $667 $ % $ % 1.3% $ % 2.1% NIEHS $642 $ % $ % 2.4% $ % 3.0% NIA $1,047 $1, % $1, % 1.5% $1, % 2.5% NIAMS $508 $ % $ % 1.6% $ % 2.4% NIDCD $394 $ % $ % 1.5% $ % 2.3% NIMH $1,404 $1, % $1, % 1.5% $1, % 2.2% NIDA $1,001 $1, % $1, % 1.6% $1, % 2.3% NIAAA $436 $ % $ % 1.4% $ % 2.1% NINR $137 $ % $ % 1.4% $ % 1.4% NHGRI $486 $ % $ % 2.1% $ % 2.7% NIBIB $297 $ % $ % 1.0% $ % 1.3% NCRR $1,133 $1, % $1, % 5.3% $1, % 5.9% NCCAM $122 $ % $ % 0.8% $ % 1.6% NCMHD $199 $ % $ % 4.6% $ % 5.2% FIC $66 $67 1.5% $68 3.0% 1.5% $68 3.0% 1.5% NLM $329 $ % $ % 1.2% $ % 2.2% OD *** $1,047 $ % $1, % 115.5% $1, % 121.7% B&F $81 $ % $ % -11.0% $ % -11.0% * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. ** The FY 2008 Request for NIAID, the FY 2008 and the FY 2008 Committee, include $300 million that would transfer to the Global Fund for HIV/AIDS, TB; the FY 2007 Joint Resolution includes approximately $99 million for the Global Fund. The recommendation for NIH for FY 2008 is 2.8% over FY 2007, when adjusted for the Global Fund transfer and the recommendation is a 1.9 percent increase when adjusted. *** The FY 2007 funding level directs $483 million to be used for the Common Fund and $69 million is for the National Children's Study; the FY 2008 directs $495 million to the Common Fund and $110.9 million to the National Children's Study; the FY 2008 Committee directs $531 million to the Common Fund and $110.9 million to the National Children's Study. The and specify the amount for the Common Fund, authorized int he 2006 NIH Reform Act, and do not transfer the 1.3 percent each IC for the Common fund that is in the budget request for FY American Society for Microbiology 1

2 AGENCY PROGRAM PB % PB % PB Centers for Disease Control & Prevention * $6,203 $5, % $6, % 7.8% $6, % 7.4% Infectious Diseases $1,804 $1, % $1, % 6.6% $1, % -1.1% Pandemic Influenza $70 $ % $ % 0.0% $ % 0.0% HIV/AIDS, Viral Hepatities, STDs, TB Prevention ** $1,010 $1, % $1, % -1.5% $1, % -3.5% Zoonotic, Vector-Borne, and Enteric Diseases $70 $ % $70 0.0% 11.1% $70 0.0% 11.1% Hanta Virus/Special Pathogens $4 $4 0.0% Lyme Disease $5 $5 0.0% West Nile Virus $37 $ % $37 0.0% 85.0% Food Safety $29 $29 0.0% Chronic Fatigue Syndrome $5 $5 0.0% Preparedness, Detection, and Control of Infectious Diseases $156 $ % $ % 26.2% $ % 20.8% Antimicrobial Resistance $17 $17 0.0% $ % 11.8% Patient Safety $3 $3 0.0% All Other Emerging Infectious Diseases $104 $ % $ % 25.7% Global Health $334 $ % $ % 0.3% $ % -12.1% Environmental Health and Injury $288 $ % $ % 5.9% $ % 2.8% Buildings & Facilities $134 $ % $ % 0.0% $ % % Terrorism Preparedness and Response (Bioterrorism) $1,541 $1, % $1, % 5.7% $1, % 8.5% * The adopted an amendment sponsored by Senators Harkin (D-IA), Kennedy (D-MA), and Specter (R-PA), that states $5,000,000 shall be for activities to reduce infections methicillin-resistant staphylococcus aureus (MRSA) and related infections. The $5 million will be provided by the appropriated sums under the Agency for Healthcare Research and Quality to focus on identifying and containing. * The adopted an amendment sponsored by Senator Coburn (R-OK), that eliminates wasteful spending by the Centers for Disease Control and Prevention, specifying that none of the funds provided to the CDC shall be used for the Ombudsman Program or additional rotating paste lights, zero-gravity chairs, or dry-heat saunas for its fitness center. * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. ** The adopted an amendment, sponsored by Senator Enzi (R-WY), that would bar the use of funds in the bill to modify funding formulas for HIV/AIDS programs under Title XXVI of the Public Health Service Act, preventing a redistribution of HIV/AIDS funds included in the bill. American Society for Microbiology 2

3 AGENCY PROGRAM PB % HHS-Wide Pandemic Influenza */** $164 $1, % $1,146 Activities Funded with No-Year Funding PB % PB HHS Office of the Secretary Public Health and Social Services $948 $ % $ % Emergency Fund ** Vaccines and Antivirals: Achieve Production Capacity and/or Buy Vaccine $543 $ % Purchase Antivirals $248 Advanced Deveopment of Antigen Sparing Techniques and Antiviral Drugs Enhance Strategic National Stockpile State and Local Preparedness Antiviral Subsidy to States Vaccine Registry Rapid Diagnostics (CDC) $79 HHS Office of the Secretary $79 $78-1.3% $78-1.3% 0.0% $78-1.3% 0.0% Activities Funded in the Agency s CDC $70 $158 $ % 0.0% $ % FDA $50 $51 2.0% NIH $35 $35 0.0% $35 0.0% 0.0% * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. **The FY 2008 Request for HHS-Wide Pandemic Influenza activites includes $870 million to fund the development of vaccines, antiviral drugs, and new tests to rapidly diagnose the disease, while $322 million would fund ongoing activities withing the CDC, FDA, NIH, and the Office of the Secretary. The FY 2008 Committee for HHS-Wide Pandemic Influenza activites includes $652 million to be available until expended fund the pre-pandemic vaccine for stockpiling,vaccine development, antiviral drugs, and research and development of diagnostic tests, while $78 million would fund ongoing activities within the the Office of the Secretary, and $158 million would be trasferred to the CDC to fund ongoing pandemic influenza activities. The FY 2008 for HHS-Wide Pandemic Influenza activities includes $870 million to fund the development of vaccines, antiviral drugs, and new tests to rapidly diagnose the disease, while $271 million would fund ongoing activities withing the CDC, NIH, and the Office of the Secretary. Since FY 2006, the Federal government has provided approximately $7 billion for pandemic influenza. FY 2007 Emergency Supplemental Pandemic Influenza HHS Office of the Secretary Public Health and Social Services Emergency Fund * $663 * These funds are intended for the purchase of antivirals, vaccine capacity building, retrofitting production facilities and accelerating the development of cell-based vaccines. Tuberculosis (TB) CDC $137 $ % $ % 7.3% NIH NIAID $129 Department of State * $50 * The adopted an amendment by Donald M. Payne, D-N.J., to shift $50 million in the bill to tuberculosis treatment, by taking $25 million within the child survival and health account and $25 million the economic support fund. According to preliminary reports, funding would go to Africa, to purchase drugs, train health care workers and build and equip and operate laboratories. American Society for Microbiology 3

4 AGENCY PROGRAM HHS-Wide Bioterrorism and Emergency Response Activities PB % PB % PB $4,148 $4, % Centers for Disease Control and Prevention $1,541 $1, % $1, % 5.7% $1, % 8.5% Biosurveillance Initiative $78 $ % $81 3.8% -8.0% $78 0.0% -11.4% CDC Capacity $137 $ % $ % 0.0% $ % 0.0% State and Local Capacity $824 $ % $ % 13.2% $ % 8.9% Strategic National Stockpile $491 $ % $ % 0.0% $ % 0.0% Anthrax Research Study $14 $0 $ % Quarantine Stations $11 National Institutes of Health $1,731 $1, % Biodefense Research $1,610 $1, % Radiological/Nuclear/Chemical Countermeasures Research $97 $96-1.0% $95-2.1% -1.0% $96-1.0% 0.0% Extramural Laboratory Construction $25 $0 Food and Drug Administration $217 $ % Food Defense $156 $ % Vaccines/Drugs/Diagnostics $55 $57 3.6% Physical Security $7 $7 0.0% $652 $ % Operations $9 $ % Preparedness and Emergency Operations $15 $ % National Disaster Medical System $47 $ % $ % 0.0% $ % 0.0% HHS Office of the Secretary Hospital Preparedness Grants ** $367 $ % $ % 8.9% $ % 6.0% Training and Curriculum Development ** $21 $0 International Early Warning Surveillance $9 $9 0.0% Media/Public Information Campaign $3 $2-33.3% Other % BARDA *** $211 $ % Advanced Research and Development **** $99 $ % $ % -25.9% $ % 0.0% BioShield Management $22 $22 0.0% $22 0.0% * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. ** Reflects comparable adjustments in FY 2006 and FY 2007 the Health Resources and Services Administration (HRSA) to the Office of the Secretary for preparedness and emergency response programs. *** Biomedical Advanced Research and Development Authority (BARDA), a newly created authority to coordinate research and produce vaccines an countermeasures against potential plagues and bioweapons. **** Reflects comparable adjustments in FY 2006 and FY 2007 of $50 million the NIAID to the Office of the Secretary for advanced development of biodefense countermeasures. **** The adopted and amendment, sponsored by Senator Burr (R-NC), that increases funding for the Public Health and Social Services Emergency Fund (PHSSEF) by $30 million to be used for the development of biodefense medical countermeasures by fully funding the Biomedical Advanced Research and Development Authority (BARDA). It specifically inserts the following under the PHSSEF section that $189,000,000 shall be used to support advanced research and development of medical countermeasures, consistent with section 319L of the Public Health Service Act. This $30 million increase is funded through a $30 million decrease in the Department of Education appropriation. American Society for Microbiology 4

5 AGENCY PROGRAM PB % PB % PB Food and Drug Administration (Includes drug, device, and animal drug user fees; and Buildings and $1,982 $2, % $1, % -16.3% $2, % 11.7% Facilities) Foods $457 $ % $ % 0.0% $ % 11.8% Human Drugs $315 $ % $ % 0.0% $ % 9.9% Biologics $145 $ % $ % 0.0% $ % 2.6% Animal Drugs and Feeds $95 $95 0.0% $95 0.0% 0.0% $98 3.2% 3.2% Medical Devices $231 $ % $ % 0.0% $ % 1.3% * The levels are based on the Appropriations Committee recommended levels. * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. Department of Homeland Security Science and Technology Directorate (Research, Development, Acquisitions, and Operations) $749 $ % $ % -1.7% $ % 6.1% Chemical and Biological * $229 $ % $ % -6.1% $ % -5.7% Laboratory Facilities ** $106 $ % $ % 1.1% $ % 18.2% University Programs $49 $ % $49 0.0% 25.6% $ % 0.0% BioWatch $78 $79 1.3% $77-1.3% -2.5% $79 1.3% 0.0% National Biosureillance Integration System $8 $8 0.0% $8 0.0% 0.0% $8 0.0% 0.0% * The FY 2007 level and FY 2008 reflect transfers of $84 million out of the Science and Technology Directorate Chemical and Biological program to the Office of Health Affairs for biosurveillance, the BioWatch program, and chemical response activities, which took place on March 31, The has also provided $28,170,000 for the Department s Science and Technology Directorate to fully fund the ongoing BioWatch generation 3 research to begin validation and pilot testing of three different prototypes and complete signatures to identify pathogens of concern. ** The FY 2008 and provide $11,000,000 is for the National Bio and Agrodefense Facility to be used to continue environmental studies necessary to determine which site will be selected for this nextgeneration biological and agricultural defense facility with construction is anticipated to begin in National Science Foundation * $5,981 $6, % $6, % 1.1% $6, % 1.9% Biological Sciences Directorate $608 $ % Research & Related Activities $4,666 $5, % $5, % 0.2% $5, % 0.5% Major Research Equipment & Facilities Construction $234 $ % $ % 0.0% $ % 0.0% Education & Human Resources $700 $ % $ % 9.7% $ % 13.5% * The adopted an amendment by Shelley Moore Capito (R-WV), to shift $10 million the NSF to the Office on Violence Against Women. American Society for Microbiology 5

6 AGENCY PROGRAM Department of Energy (Office Science) PB % PB % PB $3,797 $4, % $4, % 2.6% $4, % 2.3% Basic Energy Sciences $1,197 $1, % $1, % 0.0% $1, % 0.9% Biological and Environmental Research * / ** $462 $ % $ % 9.4% $ % 13.7% Biological Research $424 Climate Research $158 * The levels are based on the Appropriations Committee recommended levels. * The FY 2007 Joint Funding Resolution strips earmarks the BER budget, providing funding for the base BER research programs, the FY 2008 does the same. ** The FY 2008 notes that BER encompasses tow distinct efforts, Biological Research and Climate Research, and provides funding in separate subaccounts, and urges this practice in future fiscal years. Environmental Protection Agency * $7,725 $7, % $8, % 12.3% $7, % 8.0% Science & Technology (not including the Superfund Transfers) $733 $ % $ % 4.4% $ % 2.4% Office of Research and Development $555 $ % $ % 5.6% Extramural Research Grants $14 STAR Grants ** $62 $56-9.7% STAR Fellowships $9 $6-33.3% $ % 83.3% * The levels are based on the Appropriations Committee recommended levels. ** The FY 2008 does not provide a specific funding level for the STAR Grants, but states that the Committee continues to stress the importance of the STAR program and has attempted to target increases in areas that will both expand research and support STAR programs, and finds reductions to STAR funding not acceptable. Targeted increases include a $20 million increase over FY 2007 in S&T Clean Air research, and a $5 million increase in S&T Clean Water research. American Society for Microbiology 6

7 AGENCY PROGRAM PB % PB % PB U.S. Department of Agriculture * $17,812 $17, % $18, % 5.5% $18, % 4.9% CSREES $1,177 $1, % $1, % 9.7% $1, % 12.3% National Research Initiative * $190 $ % $ % -26.1% $ % -5.1% Agricultural Research Service (not including Buildings and Facilities) $1,129 $1, % $1, % 5.3% $1, % 12.9% Food Safety and Inspection Service $892 $ % $ % 0.0% $ % 0.1% APHIS (not including Buildings and $846 $ % $ % -7.5% $ % -3.6% Facilities) * The levels are based on the Appropriations Committee recommended levels. * Water Quality and Food Safety Integrated Activities, totaling $42 million, are shifted to NRI in the FY 2008 request and the Committee. The Committee does not include the transfer of programs, but does direct the Secretary to provide the requested increase for bioenergy and bio-based fuels research within the funds provided. National Aeronautics and Space Administration National Oceanic and Atmospheric Administration $16,264 $17, % $17, % 1.7% $17, % 0.9% Science $5,251 $5, % $5, % 3.3% $5, % 2.5% * The adopted an amendment, sponsored by Senator Mikulski (D-MD), appropriating $10 million to a cross-agency effort to distribute, in equal increments, to each of NASA s 10 centers for the development of educational activities in science, technology, engineering, and mathematics related to the civilian space program of the United States Operations, Research, and Facilities $2,813 $2, % $2, % 0.2% $3, % 6.4% U.S. Geologic Survey $983 $ % $1, % 5.9% $1, % 3.6% Biological Research Division $178 $ % $ % 3.3% $ % 0.6% Water Resource Division $215 $ % $ % 5.2% $ % 5.7% * The levels are based on the Appropriations Committee recommended levels. American Society for Microbiology 7

President's FY 2009 Budget Request for R&D and Public Health Programs

President's FY 2009 Budget Request for R&D and Public Health Programs Request for R&D and Public Health Programs (in millions) : http://www.whitehouse.gov/omb/budget/fy2007/ FY Final Appropriations: http://thomas.loc.gov/home/approp/app08.html FY Levels based on Documents

More information

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is

More information

Planning, Priority Setting, and Budget Development for NIH AIDS Research

Planning, Priority Setting, and Budget Development for NIH AIDS Research Planning, Priority Setting, and Budget Development for NIH AIDS Research Robert W. Eisinger, Ph.D. Office of AIDS Research s of Health Focus of Presentation Overview of OAR Priority Setting Process Budget

More information

The NIH SBIR/STTR Program & Universities

The NIH SBIR/STTR Program & Universities The NIH SBIR/STTR Program & Universities SBIR/STTR & Commercialization of University Innovations February 5, 2014 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program

More information

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion NIH OD NCI NEI NHLBI NHGRI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDCD NIDCR NIDDK NIDA NIEHS NIGMS NIMH NINDS NINR NLM CIT CSR FIC NCCAM NCMHD NCRR FY 2010 President s Budget Request Total NIH Budget Authority

More information

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education

More information

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

Pandemic Influenza: Appropriations for Public Health Preparedness and Response Order Code RS22576 January 23, 2007 Pandemic Influenza: Appropriations for Public Health Preparedness and Response Summary Sarah A. Lister Specialist in Public Health and Epidemiology Domestic Social Policy

More information

FY2019 Labor, Health and Human Services, Education Appropriations Summary

FY2019 Labor, Health and Human Services, Education Appropriations Summary Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding The Senate Appropriations Committee marked-up a bill funding the Departments of Labor, Health

More information

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

Pandemic Influenza: Appropriations for Public Health Preparedness and Response Order Code RS22576 January 23, 2007 Pandemic Influenza: Appropriations for Public Health Preparedness and Response Summary Sarah A. Lister Specialist in Public Health and Epidemiology Domestic Social Policy

More information

BD-STEP: Tackling Key Issues Across Cancer Research and Care

BD-STEP: Tackling Key Issues Across Cancer Research and Care BD-STEP: Tackling Key Issues Across Cancer Research and Care Michelle Berny-Lang, Ph.D. Program Director Center for Strategic Scientific Initiatives Office of the Director, National Cancer Institute BD-STEP

More information

FY2019 Labor, Health and Human Services, Education Appropriations Summary

FY2019 Labor, Health and Human Services, Education Appropriations Summary Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding On June 25, the House Appropriations Committee released a draft bill and accompanying report

More information

FY2018 Labor, Health and Human Services, Education Appropriations Summary

FY2018 Labor, Health and Human Services, Education Appropriations Summary Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding The Senate Appropriations Committee marked-up a bill funding the Departments of Labor, Health

More information

The NIH STTR Program

The NIH STTR Program The NIH STTR Program May 1, 2015 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program Set-asides & spending Research Institutions and Universities in STTR Discretionary

More information

On behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide

On behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide Transmitted by Jonathan Nurse, Director of Government Relations, IDSA The Infectious Diseases Society of America s (IDSA) Fiscal Year 2015 Funding Statement Submitted to the House Appropriations Subcommittee

More information

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000 NIDDK: Priorities and Perspectives Edward Doo Program Director Liver Diseases Research Branch, NIDDK National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health STOPNASH

More information

Fogarty Initiatives for Building Capacity in HIV/AIDS

Fogarty Initiatives for Building Capacity in HIV/AIDS Fogarty Initiatives for Building Capacity in HIV/AIDS April 13, 2010 Michael P. Johnson, M.D., M.P.H Deputy Director Fogarty International Center Global Health Transition in 21 st Century the unfinished

More information

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships The National Academies of SCIENCES ENGINEERING MEDICINE Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships Leadership The NIH Pain Consortium Mission

More information

FY 2015 OMNIBUS SPENDING BILL

FY 2015 OMNIBUS SPENDING BILL FY 2015 OMNIBUS SPENDING BILL Federal Agencies Relevant to Children s Health (mandatory and discretionary funding) Administration for Children and Family (ACF): $30.6 billion, a decrease of $382.8 million

More information

TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO)

TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) SENATE HELP COMMITTEE May 17, 2011 Good morning Chairman

More information

FY19 Labor, Health and Human Services, and Education Appropriations Bill

FY19 Labor, Health and Human Services, and Education Appropriations Bill FY19 Labor, Health and Human Services, and Education Appropriations Bill ASTHO Summary and Analysis Sept. 14, 2018 Last night, Congress released the bipartisan conference report for the FY19 Defense and

More information

Public Health Emergencies: Mass Dispensing in the Community

Public Health Emergencies: Mass Dispensing in the Community Public Health Emergencies: Mass Dispensing in the Community Chrissy Gamboa - Pinal County Public Health Chris Lyons, RN - Maricopa County Public Health Role of Public Health in an Disease prevention Emergency

More information

Research Training Opportunities at the National Institute on Aging

Research Training Opportunities at the National Institute on Aging Research Training Opportunities at the National Institute on Aging Arlene Jackson Jaron Lockett, Ph.D. NIA Intramural Scientific Recruiters NIA Recruitment 2010 National Institutes of Health (NIH) Mission:

More information

Thank You. Presented By. Title Sponsor. Venue Host

Thank You. Presented By. Title Sponsor. Venue Host Thank You Presented By Title Sponsor Venue Host NIDDK Research: Opportunities for Partnering Vladimir Knezevic, M.D. Senior Advisor for Commercial Evaluation, Technology Advancement Office, National Institute

More information

OBTAINING A MENTORED CAREER DEVELOPMENT AWARD: PERSPECTIVES OF A MENTOR, APPLICANT AND REVIEWER

OBTAINING A MENTORED CAREER DEVELOPMENT AWARD: PERSPECTIVES OF A MENTOR, APPLICANT AND REVIEWER OBTAINING A MENTORED CAREER DEVELOPMENT AWARD: PERSPECTIVES OF A MENTOR, APPLICANT AND REVIEWER May 15, Friday 4pm BRIEF AGENDA 1) Carol Mangione, MD MSPH- Introduction 2) Richard Kravitz, MD MSPH- Perspective

More information

Dietary Supplement Research Portfolio at the NIH, ,2

Dietary Supplement Research Portfolio at the NIH, ,2 The Journal of Nutrition Commentary Dietary Supplement Research Portfolio at the NIH, 2009 2011 1,2 Mary L. Garcia-Cazarin, 3 * Edwina A. Wambogo, 3 Karen S. Regan, 3,4 and Cindy D. Davis 3 3 Office of

More information

Overview of the NIH. National Institutes of Health (NIH)

Overview of the NIH. National Institutes of Health (NIH) Overview of the National Institutes of Health (NIH) October 16, 2008 Craig Formby, Ph.D. Distinguished Graduate Research Professor Colleges of Arts & Sciences, Medicine, and Engineering Director, Office

More information

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036 Marc Moss, MD President, American Thoracic Society Nmoore@thoracic.org; (202) 296. 9770 1150 18 th St, N.W. #300 Washington, DC 20036 STATEMENT OF THE AMERICAN THORACIC SOCIETY SUBMITTED TO THE HOUSE LABOR,

More information

Composed of 27 Institutes and Centers.

Composed of 27 Institutes and Centers. October 7, 2009 John C. Higginbotham, PhD, MPH Associate Dean for Research & Health Policy Professor and Chair, Department of Community & Rural Medicine Director, Rural Health Institute for Clinical &

More information

MARCH OF DIMES: FISCAL YEAR 2019 FEDERAL FUNDING PRIORITIES

MARCH OF DIMES: FISCAL YEAR 2019 FEDERAL FUNDING PRIORITIES TESTIMONY ON BEHALF OF MARCH OF DIMES REGARDING FISCAL YEAR 2019 APPROPRIATIONS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Testimony Prepared by Cynthia Pellegrini, Senior Vice President for Public

More information

Pandemic Influenza Preparedness and Response

Pandemic Influenza Preparedness and Response Pandemic Influenza Preparedness and Response US Department of Health and Human Services Bruce Gellin, MD, MPH Director, National Vaccine Program Office The pandemic influenza clock is ticking. We just

More information

Re: Trust for America s Health Comments on Biennial Implementation Plan for the National Health Security Strategy

Re: Trust for America s Health Comments on Biennial Implementation Plan for the National Health Security Strategy Dr. Nicole Lurie, MD, MSPH Assistant Secretary for Preparedness & Response Department of Health and Human Services Washington, DC 20201 Re: Trust for America s Health Comments on Biennial Implementation

More information

NIAID Biodefense Research Agenda

NIAID Biodefense Research Agenda NIAID Biodefense Research Agenda Deborah G. Katz, M.S., R.N. Deputy Director Office of Biodefense Research Affairs National Institute of Allergy and Infectious Diseases Princeton University September 8,

More information

Financing Influenza Vaccine R&D

Financing Influenza Vaccine R&D Financing Influenza Vaccine R&D WHO GAP-II Geneve, Switzerland July 13, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary & Director HHS/ASPR/BARDA 0 Vaccine Development is Risky, Lengthy, & Expensive

More information

ANALYSIS OF THE ADMINISTRATION S FISCAL YEAR 2004 BUDGET FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ANALYSIS OF THE ADMINISTRATION S FISCAL YEAR 2004 BUDGET FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION ANALYSIS OF THE ADMINISTRATION S FISCAL YEAR 2004 BUDGET FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION OVERVIEW: On February 20, 2003, President Bush signed the Omnibus Appropriations bill for FY

More information

CRS Report for Congress

CRS Report for Congress CRS Report for Congress Received through the CRS Web Order Code RS21181 Updated May 2, 2003 HIV/AIDS International Programs: Appropriations, FY2002 - FY2004 Raymond W. Copson Specialist in International

More information

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, 20001 202-777-2514 Donald Hoppert, Director of Government Relations, American

More information

Bioterrorism: Assessing the Threat

Bioterrorism: Assessing the Threat .United States House of Representatives Committee on Homeland Security Subcommittee on Emergency Preparedness, Response, and Communications Bioterrorism: Assessing the Threat Testimony of Tom Inglesby,

More information

Emergency Use Authorizations

Emergency Use Authorizations Emergency Use Authorizations May 26, 2016 Quality Improvement Forum Call Celia Hagan, MPH Senior Specialist, Public Policy Overview Emergency Use Authorization (EUA) authority EUA issuance process Zika

More information

CRS Report for Congress

CRS Report for Congress Order Code RS21181 Updated February 23, 2005 CRS Report for Congress Received through the CRS Web HIV/AIDS International Programs: Appropriations, FY2003-FY2006 Raymond W. Copson Specialist in International

More information

CDC Prepares Special Issue August 2006

CDC Prepares Special Issue August 2006 CDC Prepares Special Issue August 2006 Fast Facts CDC s Influenza Pandemic Operation Plan The final draft of CDC s Influenza Pandemic Operation Plan has been completed and includes more than 1600 specific

More information

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine Emerging Infectious Disease Threats Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine Plagues and History Leading causes of global deaths from infectious diseases Infectious

More information

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning APHA Annual Meeting San Francisco, California Lara Misegades, MS Director of Infectious Disease Policy November 18, 2003 Overview

More information

Questions and Answers Regarding Federal Contracts for State-Purchased Antiviral Drugs (Relenza & Tamiflu ) (07/26/06)

Questions and Answers Regarding Federal Contracts for State-Purchased Antiviral Drugs (Relenza & Tamiflu ) (07/26/06) Questions and Answers Regarding Federal Contracts for State-Purchased Antiviral Drugs (Relenza & Tamiflu ) (07/26/06) These questions were received in response to the recently executed contracts with Roche

More information

September 7, Dear Director Mulvaney:

September 7, Dear Director Mulvaney: The Honorable Mick Mulvaney Director, Office of Management and Budget Eisenhower Executive Office Building 1650 Pennsylvania Ave., NW Washington, DC 20503 September 7, 2018 Dear Director Mulvaney: As members

More information

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public

More information

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations March 2018 Update On March 23 rd, 2018, President Donald Trump signed a fiscal year 2018 (October 1,

More information

The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals

The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals june 2006 Jennifer Kates Kaiser Family Foundation The Ryan White

More information

Prepared for Members and Committees of Congress

Prepared for Members and Committees of Congress Prepared for Members and Committees of Congress Œ œ Ÿ Many potential chemical, biological, radiological, and nuclear (CBRN) terrorism agents lack available countermeasures. In 2003, President Bush proposed

More information

Testimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and

Testimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and Testimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and The Society for Healthcare Epidemiology of America (SHEA) to the U.S. House of Representatives Appropriations

More information

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES Dr. Robert P. Kadlec Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services 2017 Chemical and

More information

Infectious Diseases-HAI Idaho Department of Health and Welfare, Division of Public Health Boise, Idaho. Assignment Description

Infectious Diseases-HAI Idaho Department of Health and Welfare, Division of Public Health Boise, Idaho. Assignment Description Infectious Diseases-HAI Idaho Department of Health and Welfare, Division of Public Health Boise, Idaho Assignment Description The Fellow s assignments will primarily focus on projects within the HAI and

More information

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE Gerald R. Kovacs, PhD Director, Division of Chem/Bio/Rad/Nuc Medical Countermeasures Biomedical Advanced Research and Development Authority Assistant

More information

Conversation with Tom Inglesby on October 2, 2013

Conversation with Tom Inglesby on October 2, 2013 Participants Conversation with Tom Inglesby on October 2, 2013 Tom Inglesby, M.D., Chief Executive Officer and Director, University of Pittsburgh Medical Center (UPMC) Center for Health Security Alexander

More information

Labor, Health and Human Services & Education Labor, Health and Human Services & Education

Labor, Health and Human Services & Education Labor, Health and Human Services & Education October 7, 2016 The Honorable Harold Rogers, Chairman The Honorable Nita Lowey, Ranking Member House Appropriations Committee House Appropriations Committee Washington, DC 20515 Washington, DC 20515 The

More information

Public Safety and Health Cooperation from the Canadian Perspective

Public Safety and Health Cooperation from the Canadian Perspective 1 2 Public Safety and Health Cooperation from the Canadian Perspective Presentation by: Dr. Rainer Engelhardt Assistant Deputy Minister Infectious Disease Prevention and Control Public Health Agency of

More information

U.S. Readiness for Pandemics

U.S. Readiness for Pandemics 0 U.S. Readiness for Pandemics 5 th National Emergency Management Summit Brooklyn, NY September 15, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary for Preparedness & Response (HHS/ASPR) Director

More information

National Influenza Vaccine Summit. Atlanta April 12, 2008 Mitch Johnson

National Influenza Vaccine Summit. Atlanta April 12, 2008 Mitch Johnson National Influenza Vaccine Summit Atlanta April 12, 2008 Mitch Johnson GSK s Commitment to Influenza Market Proven track record of providing influenza vaccine to global market from vaccine headquarters

More information

Product Development for Public Health & Emerging Infections

Product Development for Public Health & Emerging Infections Product Development for Public Health & Emerging Infections Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director,

More information

State Of Tuberculosis Elimination in the United States, 2017

State Of Tuberculosis Elimination in the United States, 2017 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention State Of Tuberculosis Elimination in the United States, 2017 Philip LoBue, MD Director, Division of Tuberculosis Elimination Congressional

More information

Lita M. Proctor, Ph.D. NHGRI/NIH. for NIH Human Microbiome Project. April 11, 2011 Health Disparities Summit

Lita M. Proctor, Ph.D. NHGRI/NIH. for NIH Human Microbiome Project. April 11, 2011 Health Disparities Summit Lita M. Proctor, Ph.D. NHGRI/NIH for NIH Human Microbiome Project April 11, 2011 Health Disparities Summit Today s talk What are microbes and why are they important? What is the human microbiome and why

More information

Pandemic Influenza: U.S. Government Perspective on International Issues

Pandemic Influenza: U.S. Government Perspective on International Issues Pandemic Influenza: U.S. Government Perspective on International Issues James Lawler, M.D., M.P.H. Director for Biodefense Policy White House Homeland Security Council A 1918-Like Pandemic Would Have a

More information

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014 Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations Emily McCloskey USCA October 3, 2014 About NASTAD NASTAD is an international non-profit association of U.S. state

More information

Overview of Influenza Surveillance in Korea

Overview of Influenza Surveillance in Korea Overview of Influenza Surveillance in Korea SUNHEE PARK Korea Centers for Diseases Control & Prevention 1 contents I. II. III. Introduction Influenza Surveillance System Use of Surveillance Data 2 General

More information

Appendix 3: Federal Government Agencies Involved in Immunization

Appendix 3: Federal Government Agencies Involved in Immunization Appendix 3: Federal Government Agencies Involved in Immunization Department of Health and Human Services (HHS) Secretary of Health and Human Services Directs all HHS activities. Office of the Assistant

More information

Science. Systems Policy Process Programs People

Science. Systems Policy Process Programs People Expectations Bioterrorism - a real and present danger Anthrax attacks in the United States, 2001 Time Where to Implement Are Changes We and? Unexpected Consequences f Science Systems Policy Process Programs

More information

CIDRAP Leadership Forum Infectious Disease BRIEFING

CIDRAP Leadership Forum Infectious Disease BRIEFING Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine,

More information

Module 4: Emergencies: Prevention, Preparedness, Response and Recovery

Module 4: Emergencies: Prevention, Preparedness, Response and Recovery Module 4: Emergencies: Prevention, Preparedness, Response and Recovery Part 1: Introduction and Prevention Tamar: Hello, my name is Tamar Klaiman. I'm an Assistant Professor at the University of the Sciences

More information

Neuroscience International Funding Opportunities at NINDS & NIH

Neuroscience International Funding Opportunities at NINDS & NIH Neuroscience International Funding Opportunities at NINDS & NIH Yuan Liu, PhD Chief, Office of International Activities of Neurological Disorders & Stroke (NINDS) s of Health (NIH) U.S.A. July 20, 2007

More information

U.S. House of Representatives U.S. Senate. U.S. House of Representatives U.S. Senate

U.S. House of Representatives U.S. Senate. U.S. House of Representatives U.S. Senate Harold P. Wimmer National President and CEO December 6, 2017 The Honorable Paul Ryan The Honorable Mitch McConnell Speaker Majority Leader U.S. House of Representatives U.S. Senate H-232, The Capitol S-230,

More information

Public Health and Medical Preparedness and Response: Issues in the 110 th Congress

Public Health and Medical Preparedness and Response: Issues in the 110 th Congress Order Code RS22602 Updated June 16, 2008 Public Health and Medical Preparedness and Response: Issues in the 110 th Congress Summary Sarah A. Lister Specialist in Public Health and Epidemiology Domestic

More information

Local Government Pandemic Influenza Planning. Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator

Local Government Pandemic Influenza Planning. Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator Local Government Pandemic Influenza Planning Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator Harris County Public Health & Environmental Service Veterinarian

More information

Page 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect

More information

April 15, Barbara A. Bowman, PhD Acting Director, DCPC

April 15, Barbara A. Bowman, PhD Acting Director, DCPC April 15, 2009 Barbara A. Bowman, PhD Acting Director, DCPC National Cancer Registrars Week April 13-17, 2009 Centers for Disease Control and Prevention Office of the DIRECTOR Coordinating Office for Global

More information

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA US Proposal to Transform Response to Hepatitis B and C Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA US Proposal to Transform Response to Hepatitis B and C Burden of disease Deficiencies

More information

The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA)

The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) Written Testimony for the Record to the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding FY 2018 Appropriations for HIV/AIDS Programs Submitted by Dr. Wendy

More information

Viral Hepatitis in the U.S.: Federal Partner Update

Viral Hepatitis in the U.S.: Federal Partner Update Viral Hepatitis in the U.S.: Federal Partner Update Corinna Dan, RN, M.P.H. Office of HIV/AIDS and Infectious Disease Policy October 20, 2015 1 Institute of Medicine Report, 2010 Hepatitis and Liver Cancer:

More information

Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations

Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations Background: On June 14 th the Senate Appropriations Committee approved the

More information

GAO INFLUENZA PANDEMIC. Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning. Report to Congressional Requesters

GAO INFLUENZA PANDEMIC. Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning. Report to Congressional Requesters GAO United States Government Accountability Office Report to Congressional Requesters June 2011 INFLUENZA PANDEMIC Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning GAO-11-632

More information

Update of The National Vaccine Plan

Update of The National Vaccine Plan Update of The National Vaccine Plan Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services Presentation Outline Statutory basis for the National Vaccine Program

More information

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? 8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct

More information

Application of Single-Use Technologies in Medical Countermeasure Development & Manufacturing for Emerging Pathogens

Application of Single-Use Technologies in Medical Countermeasure Development & Manufacturing for Emerging Pathogens Application of Single-Use Technologies in Medical Countermeasure Development & Manufacturing for Emerging Pathogens BPSA s 7 th Annual Int l Single-Use Summit July 13, 2017 Mike Angelastro Director (acting),

More information

Background. Why Policymakers Should be Concerned

Background. Why Policymakers Should be Concerned Statement of the Infectious Diseases Society of America (IDSA) Concerning Project Bioshield Reauthorization Issues Presented by Martin J. Blaser, MD Before the U.S. House Energy and Commerce Committee

More information

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks

More information

Resolution. REGIONAL COMMITTEE FOR THE EASTERN MEDITERRANEAN October 2009

Resolution. REGIONAL COMMITTEE FOR THE EASTERN MEDITERRANEAN October 2009 WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Resolution REGIONAL COMMITTEE FOR THE EM/RC56/R.5 EASTERN MEDITERRANEAN October 2009 Fifty-sixth Session Agenda item 6 (a) The growing threats

More information

NIDA/FDA Collaborations

NIDA/FDA Collaborations NIDA/FDA Collaborations Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse National Institutes of Health Tobacco use is

More information

DRAFT PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE PLAN. Department of Health and Human Services. Core Document August 2004

DRAFT PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE PLAN. Department of Health and Human Services. Core Document August 2004 DRAFT PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE PLAN Department of Health and Human Services Core Document August 2004 Comments on this draft plan should be forwarded to: National Vaccine Program Office

More information

Successful Collaboration and Preparedness in Global Governance

Successful Collaboration and Preparedness in Global Governance United States Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response Successful Collaboration and Preparedness in Global Governance ISARIC meeting London,

More information

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures Joe Larsen, Ph.D. Director (Acting) BARDA Division of CBRN Medical Countermeasures January 2018 ASPR: Saving Lives

More information

REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH. AMA Policy Consolidation: Influenza and Influenza Vaccine

REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH. AMA Policy Consolidation: Influenza and Influenza Vaccine REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH CSAPH Report 5-I-12 Subject: Presented by: Referred to: AMA Policy Consolidation: Influenza and Influenza Vaccine Sandra A. Fryhofer, MD, Chair Reference

More information

Association of Public Health Laboratories

Association of Public Health Laboratories STATEMENT BY DR. Peter A. Shult ON BEHALF OF THE ASSOCIATION OF PUBLIC HEALTH LABORATORIES DIRECTOR OF THE COMMUNICABLE DISEASES DIVISION OF THE WISCONSIN STATE LABORATORY OF HYGIENE ON Beyond the Checklist:

More information

Infectious Diseases Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health Assignment Description

Infectious Diseases Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health Assignment Description Infectious Diseases Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health Lansing, Michigan Assignment Description The Michigan Infectious Disease Fellow would

More information

Modelling and Simulation in Public Health

Modelling and Simulation in Public Health Modelling and Simulation in Public Health Margaret Brandeau Department of Management Science and Engineering Stanford University My talk today Need for analysis Four modeling/simulation studies Disease

More information

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009 University of Colorado Denver Pandemic Preparedness and Response Plan April 30, 2009 UCD Pandemic Preparedness and Response Plan Executive Summary The World Health Organization (WHO) and the Centers for

More information

Preparing for the Unexpected

Preparing for the Unexpected Centers for Disease Control and Prevention Center for Preparedness and Response Preparing for the Unexpected Stephen C. Redd, MD Rear Admiral, US Public Health Service Director, Center for Preparedness

More information

The H5N1 Influenza Controversy: Implications for Science Governance. Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats

The H5N1 Influenza Controversy: Implications for Science Governance. Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats The H5N1 Influenza Controversy: Implications for Science Governance Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats Palais des Nations Room Geneva, Switzerland 17 July 2012

More information

March 8, Written Testimony for FY 2018 Appropriations for the Department of Health and Human Services

March 8, Written Testimony for FY 2018 Appropriations for the Department of Health and Human Services AMERICAN GERIATRICS SOCIETY Written Testimony for the Record Fiscal Year 2018 Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Committee on Appropriations

More information

Approximately 6 years ago, then-president

Approximately 6 years ago, then-president Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science Volume 11, Number 2, 2013 ª Mary Ann Liebert, Inc. DOI: 10.1089/bsp.2013.0042 Commentary The Pandemic and All-Hazards Preparedness

More information

Pandemic Preparedness: People, Plans, Products, and Practice. Julie Louise Gerberding, MD, MPH

Pandemic Preparedness: People, Plans, Products, and Practice. Julie Louise Gerberding, MD, MPH Pandemic Preparedness: People, Plans, Products, and Practice Julie Louise Gerberding, MD, MPH The Burden of Influenza Seasonal Influenza Globally: 250,000 to 500,000 deaths each year In the United States

More information

2013 NEHA AEC July 9 11, One Health and All-Hazards: the New Environmental Health. Want this on you?

2013 NEHA AEC July 9 11, One Health and All-Hazards: the New Environmental Health. Want this on you? One Health and All-Hazards: the New Environmental Health Christopher Eddy, MPH, REHS, RS, M.B.A. (candidate) Erik Balster, MPH, REHS, RS July 11, 2013 Next best thing to the Cover of the Rolling Stone?

More information

Public Health Preparedness and Response Update

Public Health Preparedness and Response Update Public Health Preparedness and Response Update August 3 rd, 2010 San Francisco Department of Public Health Office of Policy and Planning Preparedness Vision Vision The San Francisco Department of Public

More information